Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.

NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.

Tang Y, Blomenkamp KS, Fickert P, Trauner M, Teckman JH.

PLoS One. 2018 Aug 1;13(8):e0200897. doi: 10.1371/journal.pone.0200897. eCollection 2018.

2.

Time for the dawn of multimodal therapies and the dusk for mono-therapeutic trials for cholestatic liver diseases?

Wagner M, Fickert P.

Liver Int. 2018 Jun;38(6):991-994. doi: 10.1111/liv.13744. No abstract available.

PMID:
29863313
3.

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.

Pollheimer MJ, Racedo S, Mikels-Vigdal A, Marshall D, Bowlus C, Lackner C, Madl T, Karlsen TH, Hov JR, Lyman SK, Adamkewicz J, Smith V, Moreau E, Zollner G, Eide TJ, Stojakovic T, Scharnagl H, Gruber HJ, Stauber RE, Trauner M, Fickert P.

J Hepatol. 2018 Aug;69(2):368-377. doi: 10.1016/j.jhep.2018.04.009. Epub 2018 Apr 28.

PMID:
29709678
4.

To salt or not to salt?-That is the question in cirrhosis.

Haberl J, Zollner G, Fickert P, Stadlbauer V.

Liver Int. 2018 Jul;38(7):1148-1159. doi: 10.1111/liv.13750. Epub 2018 May 16. Review.

PMID:
29608812
5.

Case of nasogastric tube dysfunction.

Rainer F, Prenner G, Binder LP, Fickert P, Plank J.

Gut. 2018 Jan 5. pii: gutjnl-2017-315619. doi: 10.1136/gutjnl-2017-315619. [Epub ahead of print] No abstract available.

PMID:
29305431
6.

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Rainer F, Horvath A, Sandahl TD, Leber B, Schmerboeck B, Blesl A, Groselj-Strele A, Stauber RE, Fickert P, Stiegler P, Møller HJ, Grønbaek H, Stadlbauer V.

Aliment Pharmacol Ther. 2018 Mar;47(5):657-664. doi: 10.1111/apt.14474. Epub 2017 Dec 21.

PMID:
29266346
7.

Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Golob-Schwarzl N, Schweiger C, Koller C, Krassnig S, Gogg-Kamerer M, Gantenbein N, Toeglhofer AM, Wodlej C, Bergler H, Pertschy B, Uranitsch S, Holter M, El-Heliebi A, Fuchs J, Punschart A, Stiegler P, Keil M, Hoffmann J, Henderson D, Lehrach H, Reinhard C, Regenbrecht C, Schicho R, Fickert P, Lax S, Haybaeck J.

Oncotarget. 2017 Sep 5;8(60):101224-101243. doi: 10.18632/oncotarget.20642. eCollection 2017 Nov 24.

8.

Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis.

Stadlbauer V, Horvath A, Ribitsch W, Schmerböck B, Schilcher G, Lemesch S, Stiegler P, Rosenkranz AR, Fickert P, Leber B.

Sci Rep. 2017 Nov 15;7(1):15601. doi: 10.1038/s41598-017-15650-9.

9.

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P.

Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.

10.

Cholemic nephropathy - Historical notes and novel perspectives.

Krones E, Pollheimer MJ, Rosenkranz AR, Fickert P.

Biochim Biophys Acta. 2018 Apr;1864(4 Pt B):1356-1366. doi: 10.1016/j.bbadis.2017.08.028. Epub 2017 Aug 26. Review.

PMID:
28851656
11.

Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation.

Schaffellner S, Stadlbauer V, Sereinigg M, Mìller H, Högenauer C, Fickert P, Krumnikl J, Lackner C, Kniepeiss D, Stauber RE.

Am J Gastroenterol. 2017 Aug;112(8):1345-1346. doi: 10.1038/ajg.2017.171. No abstract available.

PMID:
28766583
12.

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.

Jüngst C, Stadlbauer V, Reichert MC, Zimmer V, Weber SN, Ofner-Ziegenfuß L, Voigtländer T, Spindelböck W, Fickert P, Kirchner GI, Lammert F, Lankisch TO, Krawczyk M.

Sci Rep. 2017 Aug 1;7(1):7026. doi: 10.1038/s41598-017-06268-y.

13.

New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.

Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J.

Eur J Cancer. 2017 Sep;83:56-70. doi: 10.1016/j.ejca.2017.06.003. Epub 2017 Jul 14.

PMID:
28715695
14.

Biliary bile acids in hepatobiliary injury - What is the link?

Fickert P, Wagner M.

J Hepatol. 2017 Sep;67(3):619-631. doi: 10.1016/j.jhep.2017.04.026. Epub 2017 Jul 14. Review.

PMID:
28712691
15.

Genetic loss of the muscarinic M3 receptor markedly alters bile formation and cholestatic liver injury in mice.

Durchschein F, Krones E, Pollheimer MJ, Zollner G, Wagner M, Raufman JP, Fickert P.

Hepatol Res. 2018 Feb;48(3):E68-E77. doi: 10.1111/hepr.12928. Epub 2017 Aug 26.

PMID:
28635176
16.

Life-threatening sinusoidal obstruction syndrome after high-dose chemotherapy linked to compound heterozygous mutations in ABCB11.

Stampfer L, Sperl D, Fickert P, Lackner H, Sovinz P, Ofner-Ziegenfuß L, Strenger V, Urban C, Jahnel J, Seidel MG.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26666. Epub 2017 Jun 9. No abstract available.

PMID:
28598581
17.

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

Fickert P, Hirschfield GM, Denk G, Marschall HU, Altorjay I, Färkkilä M, Schramm C, Spengler U, Chapman R, Bergquist A, Schrumpf E, Nevens F, Trivedi P, Reiter FP, Tornai I, Halilbasic E, Greinwald R, Pröls M, Manns MP, Trauner M; European PSC norUDCA Study Group.

J Hepatol. 2017 Sep;67(3):549-558. doi: 10.1016/j.jhep.2017.05.009. Epub 2017 May 18.

18.

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.

Aabakken L, Karlsen TH, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau JM, Färkkilä M, Fickert P, Hirschfield GM, Laghi A, Marzioni M, Fernandez M, Pereira SP, Pohl J, Poley JW, Ponsioen CY, Schramm C, Swahn F, Tringali A, Hassan C.

Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. Epub 2017 Apr 18.

19.

NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.

Krones E, Eller K, Pollheimer MJ, Racedo S, Kirsch AH, Frauscher B, Wahlström A, Ståhlman M, Trauner M, Grahammer F, Huber TB, Wagner K, Rosenkranz AR, Marschall HU, Fickert P.

J Hepatol. 2017 Jul;67(1):110-119. doi: 10.1016/j.jhep.2017.02.019. Epub 2017 Feb 27.

PMID:
28242240
20.

Bad memories from the gut may cause nightmares for the bile ducts.

Fickert P.

J Hepatol. 2017 Jan;66(1):5-7. doi: 10.1016/j.jhep.2016.09.016. Epub 2016 Oct 1. No abstract available.

PMID:
27702642

Supplemental Content

Loading ...
Support Center